Roberto A. Bolli

Q: What Schools Are Affiliated With Roberto A. Bolli

Roberto A. Bolli is affiliated with the following schools: University of Louisville, Medical University of South Carolina, Baylor College of Medicine, Johns Hopkins University, University of Virginia, University of Florence, Columbia University

Roberto A. Bolli's AcademicInfluence.com Rankings

Roberto A. Bolli

Medical

#880

World Rank

#1140

Historical Rank

Cardiology

#42

World Rank

#42

Historical Rank

medical Degrees

Roberto A. Bolli

Philosophy

#3162

World Rank

#5178

Historical Rank

Logic

#987

World Rank

#1595

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Roberto A. Bolli's Degrees

Doctorate Medicine Consorzio ICoN

Why Is Roberto A. Bolli Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roberto A. Bolli's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial (2011) (1344)
Human cardiac stem cells (2005) (1043)
Molecular and cellular mechanisms of myocardial stunning. (1999) (1009)
Mechanism of Myocardial “Stunning” (1990) (1001)
The Late Phase of Preconditioning (2000) (781)
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. (2007) (749)
Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. (1988) (724)
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. (2005) (661)
Marked Reduction of Free Radical Generation and Contractile Dysfunction by Antioxidant Therapy Begun at the Time of Reperfusion Evidence That Myocardial "Stunning" Is a Manifestation of Reperfusion Injury (1989) (632)
Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. (2001) (615)
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. (1999) (552)
Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. (1997) (544)
Cell Therapy for Heart Failure: A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions (2013) (526)
Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC (2001) (515)
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. (2005) (505)
Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. (1998) (480)
Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. (1989) (478)
Stem cell niches in the adult mouse heart. (2006) (475)
Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy (2004) (460)
The ubiquitous role of nitric oxide in cardioprotection. (2006) (458)
Protein Kinase C&egr; Interacts With and Inhibits the Permeability Transition Pore in Cardiac Mitochondria (2003) (457)
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. (1991) (451)
Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial Surgical Aspects and Interim Analysis of Myocardial Function and Viability by Magnetic Resonance (2012) (449)
Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology (2006) (413)
Myocardial 'stunning' in man. (1992) (412)
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. (1999) (409)
Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. (2002) (409)
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. (2000) (408)
Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction (2010) (374)
Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. (1985) (372)
Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). (1988) (361)
Cells Expressing Early Cardiac Markers Reside in the Bone Marrow and Are Mobilized Into the Peripheral Blood After Myocardial Infarction (2004) (360)
Cardiomyocyte Regeneration: A Consensus Statement. (2017) (354)
The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. (1997) (338)
Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. (1999) (332)
Guidelines for experimental models of myocardial ischemia and infarction (2018) (327)
Bone marrow cells adopt the cardiomyogenic fate in vivo (2007) (319)
An essential role of the JAK-STAT pathway in ischemic preconditioning (2001) (296)
Local Activation or Implantation of Cardiac Progenitor Cells Rescues Scarred Infarcted Myocardium Improving Cardiac Function (2008) (293)
Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. (1997) (292)
Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. (1999) (278)
New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine (2004) (277)
The nitric oxide hypothesis of late preconditioning (1998) (274)
Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. (2001) (271)
Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. (1995) (269)
Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. (1998) (268)
Preconditioning of human myocardium with adenosine during coronary angioplasty. (1997) (260)
Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. (2002) (260)
Time course and determinants of recovery of function after reversible ischemia in conscious dogs. (1988) (260)
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. (1994) (257)
Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. (1996) (255)
Stromal Cell–Derived Factor-1&agr; Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1&agr;–CXCR4 Axis (2007) (249)
Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. (1988) (248)
Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning". (1990) (242)
Transgenic Overexpression of Constitutively Active Protein Kinase C ε Causes Concentric Cardiac Hypertrophy (2000) (239)
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. (2008) (239)
Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. (1998) (236)
Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. (1985) (234)
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. (2011) (226)
Functional Proteomic Analysis of Protein Kinase C &egr; Signaling Complexes in the Normal Heart and During Cardioprotection (2001) (224)
Reperfusion-induced injury manifestations, mechanisms, and clinical relevance. (1991) (223)
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. (2004) (221)
Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. (1994) (221)
Cardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart (2010) (218)
Intracoronary Delivery of Autologous Cardiac Stem Cells Improves Cardiac Function in a Porcine Model of Chronic Ischemic Cardiomyopathy (2013) (210)
IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. (2004) (205)
Preconditioning: a paradigm shift in the biology of myocardial ischemia. (2007) (203)
Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. (1987) (203)
Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan (2008) (202)
Role of Nitric Oxide in Myocardial Preconditioning (2002) (198)
Notch1 regulates the fate of cardiac progenitor cells (2008) (195)
Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. (2003) (194)
Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. (1999) (193)
Oxygen-derived free radicals and myocardial reperfusion injury: An overview (1991) (192)
Vascular endothelial growth factor in heart failure (2013) (192)
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. (1999) (181)
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. (1992) (181)
Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. (1998) (181)
Delayed Preconditioning-Mimetic Action of Nitroglycerin in Patients Undergoing Coronary Angioplasty (2001) (177)
Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. (1997) (177)
Concise Review: Stem Cells, Myocardial Regeneration, and Methodological Artifacts (2007) (174)
Cardioprotective Effects of Short-Term Caloric Restriction Are Mediated by Adiponectin via Activation of AMP-Activated Protein Kinase (2007) (174)
Inducible Nitric Oxide Synthase Modulates Cyclooxygenase-2 Activity in the Heart of Conscious Rabbits During the Late Phase of Ischemic Preconditioning (2002) (166)
c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart (2014) (166)
Formation of large coronary arteries by cardiac progenitor cells (2008) (165)
The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. (1987) (165)
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. (1997) (162)
Time course of late preconditioning against myocardial stunning in conscious pigs. (1996) (157)
Gene Therapy With Extracellular Superoxide Dismutase Protects Conscious Rabbits Against Myocardial Infarction (2001) (153)
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. (2000) (152)
Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. (2008) (148)
Formation of protein kinase Cε-Lck signaling modules confers cardioprotection (2002) (145)
Demonstration of an early and a late phase of ischemic preconditioning in mice. (1998) (145)
Role of the Protein Kinase C-&egr;–Raf-1–MEK-1/2–p44/42 MAPK Signaling Cascade in the Activation of Signal Transducers and Activators of Transcription 1 and 3 and Induction of Cyclooxygenase-2 After Ischemic Preconditioning (2005) (143)
PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. (1999) (142)
Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. (1999) (140)
Transplantation of Bone Marrow‐Derived Very Small Embryonic‐Like Stem Cells Attenuates Left Ventricular Dysfunction and Remodeling After Myocardial Infarction (2008) (138)
The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs. (2015) (138)
Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. (2007) (136)
A1 or A3 Adenosine Receptors Induce Late Preconditioning Against Infarction in Conscious Rabbits by Different Mechanisms (2001) (133)
Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning". (1995) (132)
Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year. (2016) (130)
New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. (2004) (130)
Spontaneous Delayed Recovery of Perfusion and Contraction After the First 5 Weeks After Anterior Infarction: Evidence for the Presence of Hibernating Myocardium in the Infarcted Area (1994) (129)
Basic and clinical aspects of myocardial stunning. (1998) (128)
Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1. (2008) (125)
A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice (2013) (125)
Use of aromatic hydroxylation of phenylalanine to measure production of hydroxyl radicals after myocardial ischemia in vivo. Direct evidence for a pathogenetic role of the hydroxyl radical in myocardial stunning. (1993) (124)
Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats (2006) (124)
Cardiac Myocyte–Specific Expression of Inducible Nitric Oxide Synthase Protects Against Ischemia/Reperfusion Injury by Preventing Mitochondrial Permeability Transition (2008) (124)
Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. (2005) (123)
Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. (1993) (122)
N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia. (1986) (122)
Postischemic myocardial "stunning". Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. (1991) (121)
PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes (2000) (121)
Delayed Adaptation of the Heart to Stress: Late Preconditioning (2004) (116)
Global position paper on cardiovascular regenerative medicine (2017) (115)
"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. (2015) (115)
Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models (2011) (114)
Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. (1998) (112)
Use of fractional flow reserve versus stress perfusion scintigraphy after unstable angina. Effect on duration of hospitalization, cost, procedural characteristics, and clinical outcome. (2003) (112)
Nitric Oxide (NO) Induces Nitration of Protein Kinase Cε (PKCε), Facilitating PKCε Translocation via Enhanced PKCε-RACK2 Interactions (2002) (111)
Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions (2018) (111)
Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice (2000) (110)
Protein Kinase C &egr;–Src Modules Direct Signal Transduction in Nitric Oxide–Induced Cardioprotection: Complex Formation as a Means for Cardioprotective Signaling (2001) (110)
Adult bone marrow–derived cells: Regenerative potential, plasticity, and tissue commitment (2005) (109)
Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. (2003) (109)
Mechanism of cyclooxygenase-2 upregulation in late preconditioning. (2003) (108)
Cardiac stem cells and myocardial disease. (2008) (107)
Nitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon ), facilitating PKCepsilon translocation via enhanced PKCepsilon -RACK2 interactions: a novel mechanism of no-triggered activation of PKCepsilon. (2002) (107)
Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. (2000) (106)
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease (2015) (102)
Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. (2002) (101)
Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning (2002) (101)
The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. (1997) (99)
The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview (1996) (99)
Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit (2011) (98)
Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K+ channels in both young and aged hearts. (2005) (98)
Overexpression of Mitogen-activated Protein Kinase Kinase 6 in the Heart Improves Functional Recovery from Ischemia in Vitro and Protects against Myocardial Infarction in Vivo* (2005) (97)
Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy. (2016) (97)
The Heme Oxygenase 1 Inducer (CoPP) Protects Human Cardiac Stem Cells against Apoptosis through Activation of the Extracellular Signal-regulated Kinase (ERK)/NRF2 Signaling Pathway and Cytokine Release* (2012) (93)
Postinfarct Cytokine Therapy Regenerates Cardiac Tissue and Improves Left Ventricular Function (2006) (93)
Causative role of oxyradicals in myocardial stunning: A proven hypothesis (1998) (93)
Mechanisms of myocardial “stunning” (1991) (92)
Gene Dosage-Dependent Effects of Cardiac-Specific Overexpression of the A3 Adenosine Receptor (2002) (91)
PKCε activation induces dichotomous cardiac phenotypes and modulates PKCε-RACK interactions and RACK expression (2001) (90)
Early degradation of collagen after acute myocardial infarction in the rat. (1983) (89)
Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial "stunning" in the conscious dog and demonstration that stunning can be markedly attenuated without subsequent adverse effects. (1993) (89)
Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. (2008) (89)
A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. (2011) (89)
Nitroglycerin Induces Late Preconditioning Against Myocardial Infarction in Conscious Rabbits Despite Development of Nitrate Tolerance (2001) (89)
Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning". (1990) (89)
Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. (2001) (86)
Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning". (1990) (86)
Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction (2010) (86)
Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): A Paradigm Shift in Studies of Infarct Size Limitation (2011) (85)
Nonuniform transmural recovery of contractile function in stunned myocardium. (1989) (85)
Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. (2008) (85)
Expression of Activated PKC Epsilon (PKC ϵ) Protects the Ischemic Heart, without Attenuating Ischemic H+ Production (2002) (84)
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide (1988) (83)
Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis. (1989) (82)
Validation of a single crystal for measurement of transmural and epicardial thickening. (1986) (82)
Gene Therapy With Inducible Nitric Oxide Synthase Protects Against Myocardial Infarction via a Cyclooxygenase‐2‐Dependent Mechanism (2003) (81)
Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. (2002) (81)
Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. (2010) (81)
Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction (2017) (80)
New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types. (2018) (80)
Endothelial Nitric Oxide Synthase Plays an Obligatory Role in the Late Phase of Ischemic Preconditioning by Activating the Protein Kinase C&egr;–p44/42 Mitogen-Activated Protein Kinase–pSer-Signal Transducers and Activators of Transcription1/3 Pathway (2007) (80)
Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism. (1999) (79)
Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium. (2012) (79)
Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: a possible manifestation of myocardial stunning. (1994) (76)
The late phase of preconditioning and its natural clinical application—gene therapy (2007) (76)
Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min. (2006) (76)
Noncanonical Wnt11 Signaling Is Sufficient to Induce Cardiomyogenic Differentiation in Unfractionated Bone Marrow Mononuclear Cells (2008) (76)
Effect of superoxide dismutase and catalase, given separately, on myocardial "stunning". (1990) (76)
Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering. (2017) (74)
Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. (2002) (74)
Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. (1997) (73)
Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning. (2004) (73)
Long-Term Outcome of Administration of c-kitPOS Cardiac Progenitor Cells After Acute Myocardial Infarction (2016) (73)
Molecular Genetic Advances in Cardiovascular Medicine: Focus on the Myocyte (2004) (70)
Effect of adenosine on myocardial 'stunning' in the dog. (1995) (69)
Augmentation of Endogenous Adenosine Attenuates Myocardial 'Stunning' Independently of Coronary Flow or Hemodynamic Effects (1993) (68)
Proapoptotic Effects of Caspase-1/Interleukin-Converting Enzyme Dominate in Myocardial Ischemia (2005) (68)
HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? (2005) (66)
Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. (2000) (65)
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure) (2018) (65)
Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges. (1999) (65)
Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis. (2016) (64)
Demonstration of an early and a late phase of ischemic preconditioning in mice. (1998) (64)
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. (1999) (64)
Factors that determine the occurrence of arrhythmias during acute myocardial ischemia. (1986) (64)
Cardioprotection During the Final Stage of the Late Phase of Ischemic Preconditioning Is Mediated by Neuronal NO: Synthase in Concert With Cyclooxygenase-2 (2002) (64)
Myocardial aging (2005) (63)
Myocardial aging--a stem cell problem. (2005) (63)
Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction. (2010) (62)
PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. (2000) (62)
STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus (2016) (62)
Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced heart failure: a role for RACK1 (2001) (62)
Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning. (1999) (61)
Hepatocyte growth factor/Met gene transfer in cardiac stem cells—potential for cardiac repair (2010) (60)
Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. (1999) (60)
Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells (2009) (58)
Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. (2005) (57)
Cardioprotection Afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclooxygenase-2 via a Nuclear Factor-&kgr;B-Dependent Pathway (2007) (57)
Increased Risk of Adverse Neurocognitive Outcomes With Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors (2017) (57)
Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor. (2005) (56)
Relation of Perfusion Defects Observed with Myocardial Contrast Echocardiography to the Severity of Coronary Stenosis: Correlation with Thallium-201 Single-Photon Emission Tomography (1992) (56)
Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α (2001) (55)
Identification of Heme Oxygenase 1 (HO-1) as a Novel Negative Regulator of Mobilization of Hematopoietic Stem/Progenitor Cells (2014) (55)
Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-&kgr;B–Dependent Pathway (2009) (55)
A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial (2021) (53)
Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come (2017) (53)
Cause of death: suicide. (2006) (53)
Effect of alpha-adrenergic blockade on arrhythmias induced by acute myocardial ischemia and reperfusion in the dog. (1984) (53)
Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular Dysfunction: BM CD34, CD11b, and Clonogenic Capacity as Biomarkers for Clinical Outcomes (2014) (52)
Protein O‐GlcNAcylation Is a Novel Cytoprotective Signal in Cardiac Stem Cells (2013) (52)
COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. (2002) (52)
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. (2002) (51)
Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond (2011) (51)
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network. (2014) (51)
Hypercholesterolemia Abrogates Late Preconditioning via a Tetrahydrobiopterin-Dependent Mechanism in Conscious Rabbits (2005) (51)
Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling (2015) (50)
Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences. (2006) (50)
Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. (1999) (49)
Delayed Preconditioning-Mimetic Actions of Nitroglycerin in Patients Undergoing Exercise Tolerance Tests (2005) (49)
Influence of sulfinpyrazone and naproxen on infarct size in the dog. (1981) (49)
C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways (2015) (48)
Myocardial infarct size quantification by MR imaging early after coronary artery occlusion in dogs. (1986) (48)
The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning. (2008) (48)
Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits (2002) (48)
Cardiac Stem Cell Therapy for Cardiac Repair (2014) (47)
CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice. (2007) (47)
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). (2013) (46)
Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. (2001) (46)
Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation (2015) (45)
Effect of human recombinant superoxide dismutase on canine myocardial infarction. (1990) (45)
Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence. (2017) (45)
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications (2016) (45)
Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993) (1993) (45)
Mitochondrial PKC (cid:1) and MAPK Form Signaling Modules in the Murine Heart Enhanced Mitochondrial PKC (cid:1) -MAPK Interactions and Differential MAPK Activation in PKC (cid:1) -Induced Cardioprotection (2002) (45)
Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion (2012) (45)
Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. (2003) (45)
PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. (2001) (45)
Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. (2003) (44)
Translational Research in Cardiovascular Repair: A Call for a Paradigm Shift (2018) (44)
A Physiological Biomimetic Culture System for Pig and Human Heart Slices. (2019) (43)
Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy (2018) (43)
The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. (2007) (43)
An accurate, nontraumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery. (1990) (43)
Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair (2018) (42)
Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells* (2016) (42)
Why myocardial stunning is clinically important (1998) (42)
Emerging role of the JAK-STAT pathway as a mechanism of protection against ischemia/reperfusion injury. (2001) (40)
Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning. (1999) (40)
Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose (2018) (40)
Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction (2015) (38)
Preconditioning Human Cardiac Stem Cells with an HO‐1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart (2015) (38)
TRPA1 channel contributes to myocardial ischemia-reperfusion injury. (2019) (37)
The new circulation research: a manifesto. (2010) (37)
Loss of ischaemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C ε phosphorylation (2008) (36)
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). (2017) (36)
Nitric oxide donors attenuate myocardial stunning in conscious rabbits. (1999) (36)
The COX-2/PGI2 Receptor Axis Plays an Obligatory Role in Mediating the Cardioprotection Conferred by the Late Phase of Ischemic Preconditioning (2012) (34)
TGF-β1 enhances cardiomyogenic differentiation of skeletal muscle-derived adult primitive cells (2008) (34)
Gender and aging do not impair opioid-induced late preconditioning in rats (2003) (34)
Disparity of reperfusion arrhythmias after reversible myocardial ischemia in open chest and conscious dogs. (1986) (33)
Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview. (1993) (33)
Cardiac progenitor cells: the revolution continues. (2005) (33)
Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning. (2014) (33)
Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury. (2015) (33)
Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo. (1983) (33)
Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences (2011) (33)
The NHLBI-Sponsored Consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR)Novelty and Significance (2015) (32)
Stem cells: Cell therapy for cardiac repair: what is needed to move forward? (2017) (32)
Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. (1998) (32)
Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. (1997) (32)
MCC-134, a Single Pharmacophore, Opens Surface ATP–Sensitive Potassium Channels, Blocks Mitochondrial ATP–Sensitive Potassium Channels, and Suppresses Preconditioning (2003) (32)
An ultrasonic method for measuring tissue displacement: technical details and validation for measuring myocardial thickening (1991) (32)
Factors that determine the occurrence of reperfusion arrhythmias. (1988) (31)
Scavenging of hypochlorous acid and of myoglobin-derived oxidants by the cardioprotective agent mercaptopropionylglycine. (1990) (31)
Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits. (2004) (31)
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts (2021) (31)
Cell Therapy Needs Rigorous Translational Studies in Large Animal Models. (2015) (30)
A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells (2016) (30)
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1&bgr;– and IL-6–Related Impairment of Bone Marrow Function (2017) (30)
Endothelial nitric oxide synthase is not necessary for the early phase of ischemic preconditioning in the mouse. (2008) (30)
IN VIVO SPIN TRAPPING OF NITRIC OXIDE GENERATED IN THE SMALL INTESTINE, LIVER, AND KIDNEY DURING THE DEVELOPMENT OF ENDOTOXEMIA: A TIME‐COURSE STUDY (1996) (30)
Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha. (2001) (30)
Perspectives on Directions and Priorities for Future Preclinical Studies in Regenerative Medicine (2019) (29)
The telomere-telomerase axis and the heart. (2006) (29)
Cardioprotection involves activation of NF-κB via PKC-dependent tyrosine and serine phosphorylation of IκB-α (2003) (29)
Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty. (2007) (29)
Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors. (2001) (29)
Initial coronary occlusion improves tolerance to subsequent prolonged balloon inflations. (1989) (29)
The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis. (2007) (29)
Identification of Bone Marrow Cell Subpopulations Associated with Improved Functional Outcomes in Patients with Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial (2016) (29)
Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow. (1996) (28)
New Initiatives to Improve the Rigor and Reproducibility of Articles Published in Circulation Research. (2017) (28)
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. (2002) (28)
Assessment of regional myocardial perfusion with myocardial contrast echocardiography in a canine model of varying degrees of coronary stenosis. (1994) (28)
Quantitative assessment of left ventricular wall motion by two-dimensional echocardiography: validation during reversible ischemia in the conscious dog. (1988) (27)
Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury (2012) (27)
Reflections on the Irreproducibility of Scientific Papers. (2015) (27)
Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion. (1990) (26)
Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells. (2007) (25)
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy (2017) (24)
Clinical relevance of myocardial “stunning” (1991) (24)
Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist. (1984) (24)
Sodium Nitrite Fails to Limit Myocardial Infarct Size: Results from the CAESAR Cardioprotection Consortium (LB645) (2014) (24)
Effect of Adenosine on Myocardial Stunning (1996) (24)
Co-Activation of Nuclear Factor-κB and Myocardin/Serum Response Factor Conveys the Hypertrophy Signal of High Insulin Levels in Cardiac Myoblasts* (2014) (24)
Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy (2015) (24)
Effects of the spin trap alpha-phenyl N-tert-butyl nitrone on myocardial function and flow: a dose-response study in the open-chest dog and in the isolated rat heart. (1993) (23)
Cyclosporin in Cell Therapy for Cardiac Regeneration (2014) (22)
Bone marrow cell-mediated cardiac regeneration a veritable revolution. (2005) (22)
Deleterious effects of incomplete myocardial reperfusion on ventricular arrhythmias. (1983) (22)
Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits (2004) (22)
Protection of IB-MECA against myocardial stunning in conscious rabbits is not mediated by the A1 adenosine receptor (2001) (21)
Cardiac stem cell therapy for myocardial regeneration. A clinical perspective. (2005) (21)
Sca-1 expression is associated with decreased cardiomyogenic differentiation potential of skeletal muscle-derived adult primitive cells. (2006) (21)
Administration of Sildenafil at Reperfusion Fails to Reduce Infarct Size: Results from the CAESAR Cardioprotection Consortium (LB650) (2014) (20)
A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair. (2019) (20)
No pain, no gain: the useful function of angina. (2005) (20)
Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction (2011) (20)
Regeneration of the human heart--no chimera? (2002) (20)
Identification of major differences in postischemic myocardial “stunning” and free radical generation between open-chest and conscious dogs (1992) (20)
Gene transfer as a strategy to achieve permanent cardioprotection I: rAAV-mediated gene therapy with inducible nitric oxide synthase limits infarct size 1 year later without adverse functional consequences (2011) (20)
The increasing complexity of assessing diastolic function from ventricular filling dynamics. (1991) (20)
Myocardial Reperfusion Injury: Fact or Myth? A 1993 Appraisal of a Seemingly Endless Controversy a (1994) (19)
Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury. (1989) (19)
Stem Cell Therapy: Promising Treatment in Heart Failure? (2013) (19)
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients (2020) (19)
Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction. (2002) (19)
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial (2018) (18)
Morphine mimics ischemic preconditioning in human myocardium during PTCA (1998) (18)
Late preconditioning enhances recovery of myocardial function after infarction in conscious rabbits. (2000) (18)
Cardioprotection involves activation of NF-kappa B via PKC-dependent tyrosine and serine phosphorylation of I kappa B-alpha. (2003) (18)
Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. (1999) (18)
Safety of Intracoronary Infusion of 20 Million C-Kit Positive Human Cardiac Stem Cells in Pigs (2015) (18)
TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate. (2016) (17)
Cardiac Preconditioning during Percutaneous Coronary Interventions (2005) (17)
Decreased flow reserve in "stunned" myocardium after a 10-min coronary occlusion. (1991) (17)
After the Storm: An Objective Appraisal of the Efficacy of c-kit+ Cardiac Progenitor Cells in Preclinical Models of Heart Disease. (2020) (17)
Influence of α-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries (1985) (17)
Role of cellular proteinases in acute myocardial infarction. II. Influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat. (1983) (16)
Bone marrow cells for cardiac regeneration: the quest for the protagonist continues. (2005) (16)
Basic and Translational Research in Cardiac Repair and Regeneration (2021) (16)
Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction (1999) (16)
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. (2016) (16)
The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53‐Dependent Mechanism (2016) (16)
Cell therapy for acute myocardial infarction: Requiescat in Pace. (2020) (16)
Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning. (2003) (16)
Heart Slice Culture System Reliably Demonstrates Clinical Drug-Related Cardiotoxicity (2020) (15)
Insights into therapeutic products, preclinical research models and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC working group on cardiovascular regenerative and reparative medicine. (2020) (15)
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials (2015) (15)
Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells (2017) (15)
Common methodological problems and artifacts associated with studies of myocardial stunning in vivo (1995) (15)
Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF (2019) (14)
Dissociation between global and regional systolic and diastolic ventricular function during coronary occlusion and reperfusion. (1987) (14)
Molecular and Cellular Mechanisms Associated with Effects of Molecular Hydrogen in Cardiovascular and Central Nervous Systems (2020) (13)
Endothelial progenitor cells: neovascularization or more? (2006) (13)
Effect of ibuprofen on the healing phase of experimental myocardial infarction in the rat. (1985) (13)
Time to end the war on cell therapy (2020) (13)
Demonstration of free radical generation in the “stunned” myocardium in the intact dog (1988) (13)
Convergences of Life Sciences and Engineering in Understanding and Treating Heart Failure. (2019) (13)
Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Discovery, Translation, and Clinical Investigation (2012) (12)
The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. (2009) (12)
Myocardial ischaemia: metabolic disorders leading to cell death. (1994) (12)
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. (1997) (12)
PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. (1999) (12)
Manual of Research Techniques in Cardiovascular Medicine (2014) (12)
Effect of Molecular Weight on Sonoporation-Mediated Uptake in Human Cells. (2018) (12)
Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotection. (2004) (12)
Beneficial effects of MDL 74,405, a cardioselective water soluble alpha tocopherol analogue, on the recovery of function of stunned myocardium in intact dogs. (1994) (12)
Beneficial effects of the alpha-adrenergic antagonist nicergoline during acute myocardial ischemia and reperfusion in the dog. (1983) (11)
Increasing evidence that estrogen is an important modulator of bone marrow-mediated cardiac repair after acute infarction. (2006) (11)
Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection. (2013) (11)
Ischemic preconditioning during coronary angioplasty. (1997) (11)
Potential Strategies for Clinical Translation of Repeated Cell Therapy. (2019) (11)
Slicing and Culturing Pig Hearts under Physiological Conditions. (2020) (10)
Transcription Factor STAT3 Serves as a Negative Regulator Controlling IgE Class Switching in Mice (2018) (10)
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN Patients with Intermittent Claudication Injected with ALDH Bright Cells (PACE) Trial (2017) (10)
Influence of acute arterial hypertension on myocardial infarct size in dogs without left ventricular hypertrophy. (1984) (10)
Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischemic dog heart. (1984) (10)
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies (2021) (10)
Exercise-induced late preconditioning is triggered by generation of nitric oxide (2001) (9)
Characterization and growth of human cardiac stem cells (2005) (9)
Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. (1997) (9)
Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular DysfunctionNovelty and Significance (2014) (9)
Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy (2020) (9)
Short and Long Noncoding RNAs Regulate the Epigenetic Status of Cells. (2018) (9)
The Role of Sodium‐Hydrogen Ion Exchange in Patients Undergoing Coronary Artery Bypass Grafting (2003) (9)
Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCε and is mediated by increased iNOS activity. (2021) (9)
CAESAR’s legacy: a new era of rigor in preclinical studies of cardioprotection (2021) (9)
Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion (2017) (8)
Effects of exercise tolerance, age, and gender on the specificity of radionuclide angiography: sequential ejection fraction analysis during multistage exercise. (1987) (8)
Antioxidant enzymes attenuate myocardial stunning in the conscious dog (1990) (8)
Toward a better understanding of the metabolic effects of ischemic preconditioning in humans. (2001) (8)
Inducible cardiac-specific overexpression of cyclooxygenase-2 (COX-2) confers resistance to ischemia/reperfusion injury (2019) (8)
Abstract 1023: Transplantation Of Bone Marrow-derived Very Small Embryonic-like Stem Cells (VSELs) Improves Left Ventricular Function And Remodeling After Myocardial Infarction (2007) (8)
Current status of cell therapy for non-ischaemic cardiomyopathy: a brief overview. (2015) (8)
Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. (2018) (8)
Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS). (2012) (8)
Myocardial proteolysis during acute myocardial ischaemia. (1983) (7)
The Late Phase of Preconditioning Against Myocardial Stunning (1997) (7)
Abstract 15571: Effect of Cardiac Stem Cells in Patients with Ischemic Cardiomyopathy: Interim Results of the SCIPIO Trial (2011) (7)
Effect of transforming growth factor-beta 1 on myocardial stunning in the intact dog. (1993) (7)
Alpha adrenergic blockade does not prevent arrhythmias during coronary occlusion and reperfusion in the dog (1982) (7)
Demonstration of hydroxyl radical generation in stunned' myocardium of intact dogs using aromatic hydroxylation of phenylalanine (1991) (7)
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure (2022) (7)
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. (2014) (7)
Dandum semper est tempus: The Crucial Importance of (and Increasing Disregard for) the Test of Time. (2015) (7)
Inotrope use at separation from cardiopulmonary bypass and the role of prebypass TEE. (2004) (7)
The cornucopia of "pleiotropic" actions of statins: myogenesis as a new mechanism for statin-induced benefits? (2009) (7)
End-systolic radius to thickness ratio: an echocardiographic index of regional performance during reversible myocardial ischemia in the conscious dog. (1987) (7)
Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activation (2021) (7)
Circulation Research and human genetic studies. (2010) (7)
William Harvey and the Discovery of the Circulation of the Blood. (2019) (6)
The usefulness of the anaerobic threshold in the assessment and prognostic evaluation of the patient with dyspnea. (2012) (6)
Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries. (1985) (6)
Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice (2020) (6)
Effect of the hydrophilic alpha-tocopherol analog MDL 74,405 on detection of hydroxyl radicals in stunned myocardium in dogs. (1995) (6)
Long-Term Engraftment and Angiogenic Properties of Lentivirally Transduced Adipose Tissue-Derived Stromal Cells (2013) (6)
Abstract 381: Human Cardiac Progenitor Cells Regenerate Cardiomyocytes and Coronary Vessels Repairing the Infarcted Myocardium (2006) (6)
Adenosine preconditions human myocardium during PTCA (1996) (6)
Modulation of K ATP channels to protect the ischemic myocardium: Clinical implications (1999) (6)
Introduction to Cardiovascular Aging Compendium. (2018) (6)
Postoperative Measurements Of Ventricular Function In Man Using An Implantable Ultrasonic Sensor (1989) (6)
Global position paper on cardiovascular regenerative medicine Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes ( TACTICS ) international group for the comprehensive cardiovascular application of regenerative medicinal products (2017) (6)
Abstract 1267: Intracoronary Administration of Cardiac Stem Cells Improves Cardiac Function in Pigs with Old Infarction (2006) (6)
The TACTICS initiative: Time for a Global Alliance on Cardiovascular Regenerative Medicine (2016) (6)
O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells (2015) (6)
Bypass surgery in patients with coronary artery disease. Indications based on the multicenter randomized trials. (1987) (5)
Concealed Antidromic Re‐entrance During Rapid Atrial Pacing in the Wolff‐Parkinson‐White Syndrome (1983) (5)
Human Embryonic Stem Cell-Derived Cardiomyocytes. (2019) (5)
Detection of free radical generation in the stunned' myocardium in the conscious dog using spin tripping techniques (1991) (5)
Potential role of serotonin in dynamic coronary stenosis (1989) (5)
Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice (2020) (5)
Stromal Cell–Derived Factor-1 α Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1 α –CXCR4 Axis (2013) (5)
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction. (2019) (5)
Abstract 730: Identification and Characterization of Cardiac Stem Cells in the Pig Heart (2006) (5)
Announcing the "Meet the First Author" Page. (2017) (5)
Paul Simpson and Scientific Rigor. (2019) (5)
Inhibitory effect of a hydrophilic alpha-tocopherol analogue, MDL 74,405, on generation of free radicals in stunned myocardium in dogs. (1995) (4)
Cell therapy for heart disease: current status and future directions. (2018) (4)
Trainees in the Spotlight: Yet Another Addition to Our Portfolio. (2017) (4)
ROLE OF OXY-RADICALS IN POSTISCHEMIC MYOCARDIAL DYSFUNCTION* (1988) (4)
The effects of nitroglycerin-methoxamine combination on infarct size in conscious dogs. (1983) (4)
The sad plight of cell therapy for heart failure: causes and consequences (2022) (4)
Origin and Selection of Stem Cells for Cardiac Repair after Myocardial Infarction (2012) (4)
Role of oxygen radicals in postischemic myocardial dysfunction (“stunning”) (1990) (4)
Protein tyrosine kinase signaling is necessary for no donor-induced late preconditioning against myocardial stunning in conscious rabbits (2001) (4)
Stem Cells and Cardiac Aging (2007) (4)
Intravascular microaggregation and in vitro platelet aggregation in coronary artery disease. (1984) (4)
Use of Cardiac Stem Cells for the Treatment of Heart Failure : Translation from Bench to the Clinical Setting (4)
Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta‐analysis of randomized controlled trials (2021) (4)
Fms-Related Tyrosine Kinase 3 Expression Discriminates Hematopoietic Stem Cells Subpopulations With Differing Engraftment-Potential: Identifying the Most Potent Combination (2008) (4)
Announcing Increased Word Limits and Two New Additions to Our Article Portfolio, Perspectives and Translational Success Stories (2011) (4)
Actions Speak Much Louder Than Words: For Midcareer and Senior Investigators, the Track Record of Productivity Should Be Paramount in Selecting Grant Recipients (2014) (4)
Statistical Methods for Selecting Maximum Effective Dose and Evaluating Treatment Effect When Dose–Response is Monotonic (2014) (4)
The Impact Factor of Circulation Research Reaches a New High. (2017) (3)
Alpha-adrenergic blockade does not prevent spontaneous platelet-mediated thrombosis in stenosed coronary arteries (1982) (3)
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury (2022) (3)
Postischemic Myocardial Dysfunction (Myocardial “Stunning”): Role of Oxidative Stress (1992) (3)
An In Vivo Evidence That Murine Very Small Embryonic Like (VSEL) Stem Cells Are Mobilized into Peripheral Blood after Acute Myocardial Infarction (AMI) and Contribute to Myocardiac Regeneration. (2007) (3)
Overexpression of C-Terminal Domain of Talin-1 Enhances Survival, Migration and Differentiation of Human Cardiac Stem Cells (2012) (3)
Abstract 16843: Early Preconditioning Reduces No-reflow Independently of Infarct Size in Prolonged Ischemia and Benefits Cardiac Remodeling in Mouse (2017) (3)
Foreword—Focused Issue on Cardiac Repair by Stem Cells (2005) (3)
Introducing Yet Another Addition to Our Portfolio: Promising Young Investigators. (2016) (3)
Ten Years at the Helm of Circulation Research. (2019) (3)
Does Lethal Myocardial Reperfusion Injury Exist? A Controversy that is Unlikely to Be Settled in our Lifetime (2004) (3)
Translational Research in Cardiovascular Repair (2018) (3)
Hatter Institute Workshop on Myocardial Preconditioning, Cape Town, April 1998 (1998) (3)
Moderate ischemic injury and myocardial stunning (1993) (3)
Myocardial reperfusion injury: fact or myth? A 1993 appraisal of a seemingly endless controversy. (1994) (3)
Adenosine-induced heterogeneous perfusion accompanies myocardial ischemia in the presence of advanced coronary artery disease (1994) (3)
Oxygen Administration Does Not Influence the Prognosis of Acute Myocardial Infarction: A Meta-Analysis (2016) (2)
Reaching out to young investigators. (2014) (2)
Mechanisms of stem cell effects: insights from MRI. (2013) (2)
Abstract 1142: Effects of Culture Conditions on Cardiomyogenic Differentiation and Expansion of Bone Marrow-Derived Myocardial Tissue-Committed Stem Cells (2006) (2)
G-CSF-Induced Mobilization of Bone Marrow Stem Cells and Cardiac Repair (2012) (2)
The impact factor of circulation research rises 25%. (2013) (2)
Neurocognitive Risk With PCSK9 Inhibitors: Need for More Robust Evidence. (2017) (2)
Cardiac stem cells in patients with ischaemic cardiomyopathy – Authors' reply (2012) (2)
Heterogeneous fate of perfusion and contraction after anterior wall acute myocardial infarction and effects on left ventricular remodeling. (1998) (2)
William Harvey and the Discovery of the Circulation of the Blood. (2019) (2)
A Call to Make the Human Dimension of Science a Core Component of Scientific Journals. (2018) (2)
Nuclear Factor- (cid:107) B Plays an Essential Role in the Late Phase of Ischemic Preconditioning in Conscious Rabbits (1999) (2)
Single-dose of Synthetic MicroRNA-199a or MicroRNA-149 Mimic Does Not Improve Cardiac Function in a Murine Model of Myocardial Infarction (2021) (2)
Commentaries--another addition to the portfolio of Circulation Research. (2011) (2)
Announcing "New Leaders in Cardiovascular Science". (2013) (2)
Early and late proteolysis in acute myocardial infarction (1981) (2)
Myocardial “ stunning ” 20 years later : a summary of current concepts regarding its pathophysiology , pathogenesis , and clinical significance - (2004) (2)
Transplanted allogeneic cardiac progenitor cells secrete GDF-15 and stimulate an active immune remodeling process in the ischemic myocardium (2022) (2)
Editor's Preamble to the Profile of Robert Lefkowitz. (2015) (2)
Comparison of Repeated Doses of C-kit-Positive Cardiac Cells versus a Single Equivalent Combined Dose in a Murine Model of Chronic Ischemic Cardiomyopathy (2021) (2)
GENE THERAPY WITH INDUCIBLE NITRIC OXIDE SYNTHASE PROVIDES LONG-TERM PROTECTION AGAINST MYOCARDIAL INFARCTION WITHOUT ADVERSE FUNCTIONAL CONSEQUENCES (2005) (2)
[N-2-mercaptopropionyl-glycine improves recovery of myocardial stunning after reversible regional ischemia in conscious dogs]. (1997) (2)
Do alpha adrenergic receptors have a regulatory role influencing coronary collateral function? (1982) (2)
Circulation Research Introduces Profiles in Cardiovascular Science (2010) (2)
Recommendations for Nomenclature and Definition Of Cell Products Intended for Human Cardiovascular Use. (2021) (2)
Delayed Preconditioning Against Myocardial Stunning: Role of Nitric Oxide as Trigger and Mediator (1998) (2)
William Harvey and the Discovery of the Circulation of the Blood. (2019) (2)
ADENOSINE-INDUCED PRECONDITIONING OF HUMAN MYOCARDIUM? AUTHORS' REPLY (1998) (2)
The Impact Factor of Circulation Research Reaches Another New High. (2018) (1)
Abstract 287: Formation of Temporary Niches Is Required for Bone Marrow Cells To Adopt the Cardiomyogenic Fate In Vivo (2007) (1)
The 10 Most Read Articles Published in Circulation Research in 2015. (2013) (1)
Editor's Preamble to the Profile of Oliver Smithies. (2015) (1)
Editor's Preamble to the Profile of Eric Olson. (2015) (1)
Effect of intravenous cell therapy in rats with old myocardial infarction (2021) (1)
Abstract 366: Age-Related Myocardial Structural Changes are Associated with Early Alterations in HO-1 and COX-2 Protein Levels (2008) (1)
Transient Cell Cycle Induction in Cardiomyocytes to Treat Ischemic Heart Failure (2020) (1)
Circulation Research launches a clinical track for studies in humans. (2013) (1)
Announcing an Increased Word Limit for Original Contributions in Circulation Research (2016) (1)
Nitric oxide donors attenuate myocardial stunning in conscious rabbits. (1999) (1)
Effects of Heme Oxygenase-1 on c-Kit-Positive Cardiac Cells. (2021) (1)
Abstract 14080: A Phase II Randomized, Double-blind, Controlled Trial of Combined Mesenchymal Stromal Cells and C-kit+ Cardiac Progenitor Cells in Ischemic Heart Failure: The CCTRN CONCERT-HF Trial (2020) (1)
Early and Late Preconditioning Against Myocardial Stunning: Pathogenesis and Pathophysiology (1998) (1)
Editor's Preamble to the Profile of James Willerson. (2015) (1)
The ten most read articles published in Circulation Research in 2011. (2012) (1)
A new standard in the conflict of interest policy of the American Heart Association. (2011) (1)
Preamble to the profile of Dr Abboud and reflections on the future of American medical education. (2013) (1)
Abstract 16420: Human Cardiac Stem Cells (hCSCs) Carrying the Mother DNA Constitute a Novel Class of Resident Stem Cells With Markedly Superior Growth Reserve (2011) (1)
Progenitor cells and cardiac homeostasis (2007) (1)
ElResearch Advances Series Mechanism of Myocardial " Stunning " (2005) (1)
Abstract 16118: The Presence of the Mother DNA Identifies a Cardiac Stem Cell Class Which Promotes a Remarkable Recovery of the Infarcted Heart (2011) (1)
Anthology of Images (2018) (1)
2007 George E. Brown Memorial Lecture Use of Very Small Embryonic-Like (VSEL) Stem Cells and Cardiac Stem Cells for Repair of Myocardial Infarction (2007) (1)
Cyclooxygenase-2 in myocardial ischemia (2003) (1)
Abstract 214: rAAV-mediated Heme Oxygenase-1 Gene Therapy Affords Permanent (1 Year) Cardioprotection without Adverse Functional Consequences (2007) (1)
Ventricular remodeling: The appropriate surrogate end point for cell-based therapy? (2015) (1)
Repair of the damaged heart (2005) (1)
Circulation Research Editors’ Yearly Report: 2001 (2002) (1)
Circulation Research Launches Into Social Media (2010) (1)
Abstract 937: Antigenically-Defined Subsets of Bone Marrow Mesenchymal Stem Cells Exhibit Differential Cardiomyogenic and Angiogenic Potential (2006) (1)
Chapter 28 – Cardioprotection (2012) (1)
Abstract 5425: Nuclear Shuttling of Sirt1 Is Associated with Caloric Restriction-Induced Cardioprotection (2008) (1)
Circulation Research 2017 Best Manuscript Award Winners. (2018) (1)
The risk for myocardial infarction with cyclooxygenase-2 inhibitors [4] (multiple letters) (2005) (1)
Comparison of coliform contamination in non-municipal waters consumed by the Mennonite versus the non-Mennonite rural populations (2015) (1)
Abstract 15763: Does the Stop-Flow Technique Improve Cardiac Retention of Intracoronarily Delivered Cells? A Study of Cardiac Retention of C-kit Positive Human Cardiac Stem Cells (hcscs) After Intracoronary Infusion in a Porcine Model of Chronic Ischemic Cardiomyopathy (2014) (1)
Adenosine preconditions against ischemia-induced systolic and diastolic dysfunction during percutaneous coronary angioplasty (1998) (1)
Announcing Yet Another Article Category New Hypotheses in Clinical Medicine (2014) (1)
Abstract 14174: Transcription Factor-Induced Activation of Cardiac Gene Expression in c-kit+ Cardiac Stem Cells (2013) (1)
Clinical trials of cell therapy for heart failure: recent results warrant continued research (2022) (1)
Effect of ischemia on myocardial proteolysis (1980) (1)
Introduction to a Compendium on Regenerative Cardiology. (2018) (1)
Biomimetic cardiac tissue culture model (CTCM) to emulate cardiac physiology and pathophysiology ex vivo (2022) (1)
Correction: Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit (2012) (1)
Cardiac Stem Cells in the Failing Human Heart (2005) (1)
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial (2021) (1)
Abstract 358: Beneficial Effects of Cardiac Progenitor Cells on LV Function 1 Year after Treatment in Rats with Myocardial Infarction (2008) (1)
Recognizing the Top Reviewers for Circulation Research. (2016) (1)
Correction: Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit (2012) (1)
An obligatory role of STAT1 in the upregulation of cardioprotective proteins and delayed cardioprotection in ischemic preconditioning (2007) (0)
Abstract 15749: The Estrogen-Estrogen Receptor System in Human Cardiac Stem Cells (2011) (0)
Abstract 15091: Clonogenic Human Cardiac Stem Cells With Long Telomeres Can Be Isolated From Minute Endomyocardial Biopsies (2013) (0)
Response to letter regarding article, "Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions". (2014) (0)
SCAVENGING OF HYPOCHLOROUS ACID AND OF CARDIOPROTECTIVE AGENT MERCAPTOPROPIONYLGLY CINE MY OGLOBIN-DERIVED OXIDANTS BY THE (1990) (0)
Stem Cell Therapy and Heart Failure - A Potential Paradigm Shift in Treatment of Chronic Heart Disease. (2012) (0)
THERAPY WITH ADULT BONE MARROW-DERIVED MESENCHYMAL STEM CELLS AMELIORATES DOXORUBICIN-INDUCED CARDIOMYOPATHY (2010) (0)
MYOCARDIAL PROTECTION Enhancement of recovery of myocardial function by oxygen freeradical scavengers after reversible regional ischemia (2005) (0)
195: FLT3 expression discriminates HSC subpopulations with differing engraftment-potential (2007) (0)
UseofAromatic Hydroxylation ofPhenylalanine toMeasureProduction ofHydroxyl Radicals After Myocardial Ischemia InVivo Direct Evidence foraPathogenetic RoleoftheHydroxyl Radical inMyocardial Stunning (1993) (0)
Abstract 2112: Immortal DNA Strand and Human Cardiac Stem Cell Renewal (2009) (0)
A STITCH IN TIME DOES NOT ALWAYS SAVE NINE: RAPID ONSET HEART FAILURE SECONDARY TO MITRAL STENOSIS POST MITRAL VALVE REPAIR IN A YOUNG PATIENT (2014) (0)
Abstract 3029: Major Impact of Genetic and Physiologic Variables on Ischemia/reperfusion Injury in the Murine Heart (2009) (0)
Abstract 20671: Ephrin A1/EphA2 Signaling Promotes Mobilization of Human Cardiac Stem Cells in the Infarcted Heart (2010) (0)
Editor's Preamble to the Profile of Louis Ignarro. (2015) (0)
Heme Oxygenase-1 Via a Nuclear Factor-Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection (2009) (0)
Protein O‐GlcNAcylation – A Novel Cell Survival Signal in Cardiac Stem Cells (2012) (0)
Abstract 368: Identification of Inducible Nitric Oxide Synthase in Peripheral Blood Cells as a Mediator of Myocardial Ischemia/Reperfusion Injury (2008) (0)
Abstract 18726: Heme Oxygenase-1 (HO-1) Regulates microRNA-122-5p and -365-3p against Apoptosis in Cardiac Progenitor Cell (CPC) Therapy (2017) (0)
Abstract 19808: Short Term Outcomes After Use of Bone Marrow Transplantation for Management of Heart Failure: A Meta-analysis (2014) (0)
Establishment and validation of a pre‐clinical, multi‐center, multi‐species consortium for the assessment of infarct size‐reducing agents: CAESAR (Consortium for the preclinicAl assESsment of cARdioprotective therapies) (LB698) (2014) (0)
Circulation Research Introduces News & Views (2010) (0)
Abstract 1916: miR-34a Induces Senescence of Human Cardiac Progenitor Cells (2009) (0)
Abstract 551: The Cardioprotection Afforded by Inducible Nitric Oxide Synthase Is Mediated by Heme Oxygenase-1 (2007) (0)
STEM CELL PLASTICITY: REGENERATION OF FUNCTIONAL MYOCARDIUM FROM BONE MARROW STEM CELLS (BMSC). (2004) (0)
Transdermal nitroglycerin induces late preconditioning against infarction despite nitrate tolerance (2001) (0)
Abstract 9546: Effects of Endogenous Hydrogen Sulfide on Differentiation of Cardiac Stem Cells (2011) (0)
Compromised cardiac performance and remodeling in collagen type VI deficient mice after myocardial infarction (2009) (0)
HDAC1 Depletion in Human Cardiac Mesenchymal Stromal Cells Facilitates Paracrine‐Mediated Endothelial Cell Growth and Tube Formation through a Mechanism Involving Enhanced bFGF Production and Secretion (2017) (0)
Profiles in Cardiovascular Science (2010) (0)
Abstract 15861: ER Stress and ATF3 Play Essential Roles in the Cardioprotective Effects of the Late Phase of Ischemic Preconditioning (2010) (0)
Grafting: Results of the EXPEDITION Study Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of (2013) (0)
Abstract 15555: Administration of c-Kit+ Cardiac Stem Cells (CSCs) Results in Increased Proliferation and Cardiac Content of CSCs 1 Year Later (2014) (0)
The New Circulation Research (2010) (0)
Abstract 16354: Improved Myocardial Function in Patients with Chronic Ischemic Heart Disease Treated with Transendocardial Delivery of Bone Marrow Mononuclear Cells Depends Upon Input Cell Phenotype and Function (2012) (0)
Abstract 012: Directed Differentiation of c-kit+ Human Cardiac Stem Cells in vitro (2013) (0)
Abstract 303: Migration of Cardiac Progenitor Cells to the Scarred Infarcted Myocardium is Mediated by Matrix Metalloproteinases and Chemotactic Factors (2008) (0)
Abstract 1390: Cardiac Stem Cells Regenerate the Coronary Vasculature and the Scarred Infarcted Myocardium in Rats (2006) (0)
Abstract 16933: Targeted Inhibition of Histone Deacetylase 1 Promotes the Activation of a Cardiomyogenic/Vasculogenic Genetic Program in Human Cardiac-derived Mesenchymal Stromal Cells (2015) (0)
Abstract 3333: Chronic AMD3100 Antagonism of SDF1-CXCR4 Signaling Exacerbates Cardiac Injury After Myocardial Infarction Despite Increased Recruitment of ckitpos Progenitors (2009) (0)
Evidence for Free Radical Generation in Vivo during Cardiac Ischemia and Reperfusion (1990) (0)
Abstract 155: C-kit+ Cardiac Progenitor Cells Contain a Subpopulation of Slowly Adherent Cells With Higher Cardiomyogenic and Pro-angiogenic Profile (2015) (0)
Abstract 354: Optimization of Extracellular Vesicles Isolation From Cardiac Mesenchymal Cells (2016) (0)
REVIEW Guidelines in Cardiovascular Research Guidelines for experimental models of myocardial ischemia and infarction (2018) (0)
Protein O‐GlcNAcylation Promotes Post‐hypoxic Survival of Cardiac Progenitor Cells (2011) (0)
Abstract 20687: The Histone Methyltransferase Smyd3 Promotes the Myocyte Commitment of Human Cardiac Stem Cells (2010) (0)
Abstract 22: CXCR4 Expression on Endogenous Bone Marrow Stem/Progenitor Cells is Crucial for Preservation of Myocardial Function After MI (2014) (0)
Abstract 207: Intracoronary Administration of Cardiac Stem Cells Repairs Infarcted Myocardium and Improves Cardiac Function in Rats with Old Infarction (2007) (0)
Transient gene therapy using cell cycle factors reverses renin–angiotensin–aldosterone system activation in heart failure rat model (2022) (0)
Abstract 1421: Role of c-Src Tyrosine Kinase in Ischemic Preconditioning: Formation of Focal Adhesion Kinase - Paxillin Complex Confers Cardioprotection (2006) (0)
Another addition to our article portfolio: announcing Brief UltraRapid Communications. (2010) (0)
178. Effect of Heme Oxygenase-1 Overexpression on DNA Synthesis of Adult Cardiac Progenitor Cells Under Hypoxia (2016) (0)
Effect of naproxen and sulfinpyrazone on myocardial infarction size (1979) (0)
A Murine Model of Cardiac Arrest by Exsanguination (2013) (0)
Abstract 10779: Exosomes Derived From Cardiac Progenitor Cells Attenuate Left Ventricular Dysfunction and Remodeling After Myocardial Infarction via Epigenetic Modulations (2018) (0)
MYOCARDIAL FUNCTION ASSESSMENT DURING CARDIOPULMONARY BYPASS SURGERY (1988) (0)
Abstract 226: Long-Term Protection Against Myocardial Infarction Provided by rAAV-Mediated Endothelial Nitric Oxide Synthase Gene Therapy (2006) (0)
Preconditioning of human myocardium with bradykinin during PTCA (1998) (0)
CXCR4+ CD45− Tissue-Committed Stem Cells (TCSC) for Myocardium Reside in the Bone Marrow, Are Mobilized into the Peripheral Blood during Myocardial Infarction, and “Home” to Infarcted Myocardium in CXCR4-SDF-1 and HGF/SF-c-Met Dependent Manner. (2004) (0)
Abstract 1265: Cardiac Stem Cell Niches Control Cardiomyogenesis in the Adult Mouse Heart (2006) (0)
Abstract 3030: rAAV-mediated Extracellular Superoxide Dismutase (ecSOD) Gene Therapy Produces Permanent Cardioprotection (2009) (0)
O‐GlcNAc Signaling Regulates Cardiomyogenesis of Cardiac Progenitor Cells (2011) (0)
Abstract 3286: IGF-2 Enhances Human Cardiac Progenitor Cell Differentiation and Myocardial Regeneration After Infarction (2009) (0)
Abstract 213: The Late Phase of Ischemic Preconditioning Is Abrogated by a Specific Prostaglandin I2 Receptor Antagonist (2007) (0)
Abstract 13247: Preconditioning Cardiac Progenitor Cells With Biologically Active Gases (NO and CO) Enhances Cell Survival Through Activation of Survival Signal Pathways (2010) (0)
Editor's Note Circulation Research Introduces Profiles in Cardiovascular Science (2010) (0)
Reproducibility of Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices (2022) (0)
From the Cardiovascular Cell Therapy Research Network Bone Marrow Mononuclear Cell Therapy for Acute Myocardial Infarction : A Perspective (2014) (0)
Protein O‐GlcNAcylation Exerts Mitogenic Effects in Cardiac Progenitor Cells (2011) (0)
Recognizing the Top Reviewers of 2017 for Circulation Research. (2018) (0)
Abstract 11094: Cardiac Endothelial Progenitor Cells Isolated from Human Atrial Appendages Demonstrate Biological and Functional Properties Typical of Endothelial Cells (2011) (0)
Upregulating Heme Oxygenase-1 Via a Nuclear Factor-{kappa}B-Dependent Pathway Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by (2009) (0)
Abstract 208: Reliable Biomimetic Culture System for Pig and Human Heart Slices (2019) (0)
Nitric oxide induces activation of pkcϵ via a cGMP-dependent mechanism in adult rabbit cardiac myocytes (2001) (0)
Abstract 12113: STAT1 Transcription Factor is Required for the Delayed Protection Against Cardiomyocyte Apoptosis by Ischemic Preconditioning (2013) (0)
Abstract 15567: Glutamine Regulates Cardiac Stem Cell Metabolism and Competency (2014) (0)
AHEART May 45/5 (1999) (0)
Reconstitution of Large Coronary Arteries by Cardiac Stem Cells: A Biological Bypass (2005) (0)
DOSE-DEPENDENT EFFECTS OF INTRACORONARY CARDIAC STEM CELLS IN RATS WITH ACUTE MYOCARDIAL INFARCTION (2015) (0)
Abstract 15359: Alterations in Ephrin A1/EphA2 Signaling Causes Defects in the Migration of Senescent Human Cardiac Stem Cells (2011) (0)
Cardioprotection involves activation of NF- (cid:1) B via PKC-dependent tyrosine and serine phosphorylation of I (cid:1) B- (cid:2) (2003) (0)
Understanding the jargon: A glossary of terms used (and misused) in the study of ischaemia and reperfusion: Comments (1993) (0)
Editor's Preamble to the Profile of Eugene Braunwald. (2015) (0)
Abstract 225: SDF1{alpha} Preconditions the Heart: Role for a Functional Cardiac SDF1{alpha}-CXCR4 Axis (2006) (0)
Bone Marrow Cell Characteristics Associated with Patient Profile and Cardiac Performance Outcomes in the LateTIME-CCTRN Trial (2016) (0)
Clinical Progress Myocardial 'Stunning' in Man (2005) (0)
New insights into cardioprotection, gained by adopting the CAESAR standards of rigor (2022) (0)
Abstract 3903: IGF-1, Angiotensin II and Human Cardiac Progenitor Cell Function (2008) (0)
Correction: Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit (2012) (0)
Stromal Cell–Derived Factor-1 (cid:1) Confers Protection Against Myocardial Ischemia/Reperfusion Injury Role of the Cardiac Stromal Cell–Derived Factor-1 (cid:1) –CXCR4 Axis (2007) (0)
Adenosine receptor subtypes in the heart: therapeutic opportunities and challenges. (1999) (0)
Abstract 18631: The Histone Methyltransferase Smyd3 Modulates Growth and Differentiation of Human Cardiac Stem Cells (2012) (0)
Abstract 577: Origin and Therapeutic Efficacy of Human Cardiac Progenitor Cells (2007) (0)
Targeted disruption of cox-2 gene abrogates the late phase of ischemic preconditioning (2007) (0)
Abstract 18986: Unopposed TNF/TNFR1 Signaling Prevents Therapeutic Benefit From Cardiac Stem Cell Therapy After Reperfused Myocardial Infarction in Mice (2015) (0)
Abstract 221: The Beneficial Effects of Cytokine Combinations are Sustained During Long-term Follow-up (2006) (0)
Abstract 10138: Extracellular Superoxide Dismutase (ecSOD) is Essential for Ischemic Preconditioning (PC): Studies in ecSOD Null and Cardiac Specific Overexpressing Mice (2011) (0)
The 10 Most Read Articles Published in Circulation Research in 2016. (2017) (0)
CONTINUOUS MONITORING OF LEFT VENTRICULAR FUNCTION AFTER CARDIAC SURGERY (1989) (0)
The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Authors' reply (2005) (0)
Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) international group for the com- prehensive cardiovascular application of regenerative medicinal products (2018) (0)
Cyclooxygenase-2 does not mediate late preconditioning against infarction induced by adenosine A1 or A3 receptors (2001) (0)
Handle Anywhere: A Mobile Robot Arm for Providing Bodily Support to Elderly Persons (2022) (0)
, CXCR 4 Axis − α Derived Factor-1 − Ischemia / Reperfusion Injury : Role of the Cardiac Stromal Cell Confers Protection Against Myocardial α Derived Factor-1 − (2007) (0)
PSS144 – Impact of Type 2 Diabetes on Cardiac Stem Cell Phenotype and Therapeutic Efficacy (2013) (0)
Contents of Volume 74 (2000) (2000) (0)
A Real-Time Algorithm for Identifying Gait in a Sensory Substitution System (2019) (0)
Myocardial Infarct Size in Humans (2005) (0)
Abstract 1392: G Protein Coupled Receptor Kinase 6 Couples Stromal Cell Derived Factor-1{alpha}-CXCR4 Signaling to ERK/AKT Activation in Rat Cardiac Stem Cells (2008) (0)
Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor- (cid:1) B–Dependent Pathway Molecular Cardiology (2009) (0)
Editor's Preamble to the Profile of Robert Jennings. (2015) (0)
1 Revised M 4 : 06690 Over-expression of MKK 6 in the Heart Improves Functional Recovery from Ischemia In Vitro and Protects Against Myocardial Infarction In Vivo (2004) (0)
ST-I-2 Myocardial protection of late preconditioning ∼Its mechanisms and therapeutic applications ∼ (2002) (0)
Abstract 12445: A Detailed Analysis of Peripheral Blood Cytokines 2-3 weeks After Acute Myocardial Infarction: IL-6-Related Impairment of Bone Marrow Function (2015) (0)
δ-Opioid Receptor-Induced Late Preconditioning against Myocardial Infarction Is Mediated by Constitutive Nitric Oxide Synthase in Conscious Rabbits (2003) (0)
WALL THICKENING PROBES FOR ASSESSMENT OF MYOCARDIAL FUNCTION IN CARDIAC SURGERY (1988) (0)
Abstract 20660: Defective Trafficking of Senescent Human Cardiac Stem Cells: Role of EphrinA1/EphA2 Interaction. (2010) (0)
Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced cardiac hypertrophy and failure: A role for RACK1 (2001) (0)
Vascular Endothelial Growth Factor A (2013) (0)
PRECLINICAL EFFICACY STUDY IN A PORCINE MODEL FOR A NOVEL GENE THERAPY APPROACH TO PROMOTE CARDIOMYOCYTE PROLIFERATION IN ISCHEMIC CARDIOMYOPATHY (2021) (0)
DOXORUBICIN-INDUCED MYOCARDIAL INFLAMMATION, APOPTOSIS AND REMODELING ARE ATTENUATED BY CARDIAC-SPECIFIC TRANSGENIC INHIBITION OF NUCLEAR FACTOR-KAPPAB (2011) (0)
Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF (2019) (0)
Mitochondrial PKC&egr; and MAPK Form Signaling Modules in the Murine Heart: Enhanced Mitochondrial PKC&egr;-MAPK Interactions and Differential MAPK Activation in PKC&egr;-Induced Cardioprotection (2002) (0)
Contents Of Volume 100 (2005) (2005) (0)
Abstract 360: Genetic Deletion of IL-6 Ameliorates Left Ventricular Dysfunction and Remodeling after a Reperfused Myocardial Infarction (2008) (0)
With Appreciation (1994) (0)
Introduction (2003) (0)
Abstract 14950: Overexpression of Cardiomyocyte-specific Extracellular Superoxide Dismutase Increases Nitric Oxide Bioavailability and Reduces Infarct Size after Ischemia/ Reperfusion. (2010) (0)
Thromboxane B 2 in Cardiac Lymph Effect of Superoxide Dismutase and Catalase During Myocardial Ischemia and Reperfusion (2005) (0)
Abstract 16015: Human Cardiac Stem Cell Trafficking is Impaired with Age due to Alterations in Ephrin A1/EphA2 Signaling (2012) (0)
Role of oxy-radicals in postischemic myocardial dysfunction (”myocardial stunning”) (1988) (0)
Abstract MP213: Activation Of Biosynthetic Pathways Regulates Cardiomyocyte Cell Cycle Induction In Human Cardiomyocyte (2021) (0)
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy (2018) (0)
Abstract 5418: Deficiency of Glutathione-S-transferase P (GSTP)-mediated Detoxification of Lipid Peroxidation Products Increases Myocardial Ischemia-Reperfusion Injury (2008) (0)
Correction: The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-related kinase (ERK)/NRF2 signaling pathway and cytokine release. (2019) (0)
Unique energetic profile of cardiac progenitor cells (2011) (0)
Editor's Preamble to the Profile of Joseph Goldstein and Michael Brown. (2015) (0)
Myocardial ischaemia proteolysis during acute myocardial (2007) (0)
Protective effects of sulfinpyrazone in acute myocardial ischemia and reperfusion (1982) (0)
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy (2017) (0)
Abstract 14850: Heme Oxygenase-1 (HO-1) Promotes c-Kit+ Cardiac Stem Cell Migration via the SDF-1a-CXCR4 Signaling Pathway (2013) (0)
Ventricular dilation and remodeling after anterior q-wave infarction: Effects of delayed reperfusion in the infarcted area (1996) (0)
Abstract 212: Pharmacologic Late Preconditioning With Opioid {delta}1-agonist Confers Cardio- And Neuroprotetive Benefits During Cardiac Arrest (2007) (0)
Abstract 1122: The Mammalian Heart Contains Vascular and Myocyte Niches (2007) (0)
Title Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia / reperfusion (2012) (0)
Abstract 3422: Asymmetric Division of Human Cardiac Progenitor Cells Involves Immortal DNA Strand Cosegregation (2008) (0)
Therapy with c-kitPOS Cardiac Stem Cells for Ischemic Cardiomyopathy (2016) (0)
Functional Proteomic Analysis of Protein Kinase C ε Signaling Complexes in Preconditioning. (2000) (0)
Abstract 1000: Dichotomous Roles Of TNF-{alpha} Receptors p55 And p75 In Acute Ischemia/reperfusion Injury And Late Ischemic Preconditioning (2007) (0)
Disparate effects of alpha-blocking agents in experimental myocardial ischemia (1981) (0)
Abstract 238: Targeted Disruption of the Prostacyclin Receptor Gene Abrogates the Late Phase of Ischemic Preconditioning (2006) (0)
The Enigma of LeftVentricular Hypertrabeculation (0)
Cardiac Progenitor Cells Rescue Scarred Infarcted Myocardium (2006) (0)
18 Prostacyclin attenuates oxidative damage of myocytes via stimulation of EP3 receptor (2002) (0)
Abstract 1114: Deregulation of MicroRNAs in the Heart of c-kit-Defective Mice (2007) (0)
Identification of Heme Oxygenase 1 (HO-1) as a Novel Negative Regulator of Mobilization of Hematopoietic Stem/Progenitor Cells (2014) (0)
Abstract 17765: Embryonic Origin of Adult Resident Cardiac Stem Cells (2010) (0)
The risk for myocardial infarction with cyclooxygenase-2 inhibitors. (2005) (0)
Cardioprotection of glutathione S‐transferase P against ischemia‐reperfusion injury (2008) (0)
Abstract 1609: Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Has A Potent Cardioprotective Effect in Both Young and Aged Mice (2006) (0)
PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction (2022) (0)
Under new management: A six-month progress report on Circulation Research. (2000) (0)
Global systolic and diastolic left ventricular function during experimental coronary occlusion and reperfusion: Relation to regional myocardial function (1985) (0)
Abstract 20351: Transient Receptor Potential Ankyrin-1 Deficiency in Mice Protected Against Myocardial Ischemia-Reperfusion Injury (2017) (0)
Abstract 1614: Inducible Nitric Oxide Synthase Upregulates Heme Oxygenase-1 (HO-1) in Myocardium by Enhancing Nrf2 Phosphorylation and Binding to the HO-1 Promoter (2008) (0)
Abstract 222: Mechanism of the Late Phase of Exercise-Induced Preconditioning against Myocardial Infarction (2006) (0)
The Enigma of Left€Ventricular Hypertrabeculation (0)
Abstract 14958: The Effect of Early Phase of Ischemic Preconditioning on the Leptin Resistant Diabetic Heart (2013) (0)
Life and Death of Cardiac Stem Cells (2006) (0)
Abstract 13179: Ultrasound Contrast Agents Enhance in vivo Delivery of Mir-302b Mimics and Antimir-34a to Mouse Hearts (2019) (0)
Abstract 10492: Preclinical Evaluation of Transient and Cardiomyocyte Specific Gene Therapy for the Treatment of Subacute Ischemic Heart Failure (2021) (0)
Abstract 14391: Transient Cell Cycle Induction in Cardiomyocytes is a Promising Approach to Treat Ischemia Induced Heart Failure (2020) (0)
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy (2018) (0)
Abstract 903: Human Cardiac Progenitor Cells (2006) (0)
Introducing the NHLBI Page: A New Feature to Facilitate Communication Between the NHLBI and the Cardiovascular Research Community (2011) (0)
Abstract 18314: Aging, Diabetes and Ischemic Cardiomyopathy Do Not Deplete the Pool of Cardiac Stem Cells in the Human Heart (2010) (0)
Abstract 9875: Ho-1/co Mediated Human Cardiac Stem Cell Survival Through Activation of Survival Signal Pathways and Cytokine Effects (2011) (0)
Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy (2020) (0)
Announcing “New Methods in Cardiovascular Biology” (2010) (0)
940-74 Spontaneous Delayed Reperfusion of Infarcted Area Limits Progressive LV Remodeling After Anterior Q-Wave MI (1995) (0)
Abstract 5423: rAAV-Mediated Gene Therapy with Inducible Nitric Oxide Synthase (iNOS) Affords Permanent Cardioprotection (1 Year) without Adverse Functional Consequences (2008) (0)
Glutathione-S-transferase-P deficiency in mice enhances myocardial sensitivity to ischemia–reperfusion (2007) (0)
Correction: Transplanted allogeneic cardiac progenitor cells secrete GDF-15 and stimulate an active immune remodeling process in the ischemic myocardium (2022) (0)
Magnetization Transfer as a Teeihlbigife for In Vivo Assessment Of Altered Energy Transfer in Cardiac Hypertrophy* (2016) (0)
Abstract 704: Cardiac Progenitor Cell Aging Is Responsible for Organ Aging (2007) (0)
Abstract 18896: Casein Kinase 1α Gene Therapy Facilitates Cardiac Regeneration After Myocardial Infarction in Mice (2016) (0)
Roberto Bolli and for the Editors in 2011 Circulation Research The Ten Most Read Articles (2012) (0)
Abstract 132: Cardiomyocyte Specific Conditional Overexpression Of Stromal Cell Derived Factor 1 Facilitates Cardiac Regeneration After Permanent Coronary Artery Ligation In Mice. (2014) (0)
Keynote Lecture : Use of Cardiac Stem Cells to Repair Infarcted Myocardium(Cardiac Regeneration,AHA-JCS Joint Symposium (M),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (0)
Abstract 219: Obligatory Role of Nrf2-Dependent Upregulation of Extracellular Superoxide Dismutase in Cardioprotection Afforded by Heme Oxygenase-1 Gene Therapy (2006) (0)
Abstract 9256: Overexpression of C-Terminal Domain of Talin-1 Enhances Survival, Migration, and Differentiation of Human Cardiac Stem Cells (2011) (0)
Oxidative Stress in the Pathogenesis of Postischemic Ventricular Dysfunction (Myocardial “Stunning”) (1993) (0)
Ectopic Cardiogenic Transcription Factor Expression Augments the Anti‐fibrogenic Activity of Administered Cardiac Mesenchymal Stromal Cells in a Model of Chronic Ischemic Cardiomyopathy (2019) (0)
Abstract 1276: Pluripotent Bone Marrow (BM)-Derived Very Small Embryonic-Like (VSEL) Stem Cells are Mobilized after Acute Myocardial Infarction in Mice (2007) (0)
Abstract 1615: Mice with Inducible Cardiac-Specific Overexpression of Cyclooxygenase-2 Are More Resistant to Ischemia/Reperfusion Injury (2008) (0)
Cardioprotection in iNOS transgenic mice is independent of mitochondrial biogenesis. (2008) (0)
Abstract 1618: Role of Nitric Oxide in Regulation of Myocardial Glucose Metabolism; A Potential Mechanism of Cardioprotection (2008) (0)
A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial (2020) (0)
Myocardial “reperfusion injury”: Fact or fiction? (1990) (0)
Insulin Levels in Cardiac Myoblasts Conveys the Hypertrophy Signal of High Myocardin / Serum Response Factor B and κ Co-Activation of Nuclear Factor-Gene Regulation : (2014) (0)
Sensory Substitution in Stroke Patients with a Novel Vibrotactile System (2018) (0)
Abstract 12756: Cardioprotection by Heme Oxygenase-1 is Mediated by Cyclooxygenase-2 but not Inducible Nitric Oxide Synthase (2010) (0)
Late-Breaking Basic Science Abstracts From the American Heart Association’s Scientific Sessions 2020 (2010) (0)
Salutary Actions of Nicergoline* During Experimental Coronary Artery Occlusion and Reperfusion (1986) (0)
Enhanced PKC b II translocation and PKC b II-RACK 1 interactions in PKC e-induced heart failure : a role for RACK 1 (2001) (0)
Adenosine-induced preconditioning of human myocardium? [2] (multiple letters) (1998) (0)
Abstract 429: The Failing Senescent Heart Contains a Pool of Functionally Competent Progenitor Cells (2007) (0)
Abstract 233: Cardioprotection with Postconditioning is Enhanced by the Late Phase of Ischemic Preconditioning via a COX-2-Mediated Mechanism in Conscious Rats (2006) (0)
Tumor necrosis factor receptors have divergent effects on NF‐kB activation in cardiac progenitor cells (2011) (0)
Editors’ Preamble to The Journal of Cardiovascular Aging (2021) (0)
Effect of molecular weight on sonoporation-mediated uptake in human cardiac cells (2017) (0)
USE OF THICKENING FRACTION (TF) AS AN INDEX OF MYOCARDIAL FUNCTION DURING THE POSTOPERATIVE PERIOD (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roberto A. Bolli?

Roberto A. Bolli is affiliated with the following schools:

Roberto A. Bolli's Academic­Influence.com Rankings

Roberto A. Bolli's Degrees

Why Is Roberto A. Bolli Influential?

Roberto A. Bolli's Published Works

Published Works

What Schools Are Affiliated With Roberto A. Bolli?

Roberto A. Bolli's AcademicInfluence.com Rankings